PT  - JOURNAL ARTICLE
AU  - Gwinyai Masukume
AU  - Julio González-Álvarez
AU  - Victor Grech
TI  - International Journal of Epidemiology peer reviewers: global and gender distribution
AID  - 10.1101/2020.05.14.20101964
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.14.20101964
4099  - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101964.short
4100  - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101964.full
AB  - The science of epidemiology studies and analyses the patterns, distributions and determinants of health-related entities. Peer review is crucial to the biomedical journal ecosystem. Furthermore, gender inequality persists in science and improving gender representation is a key international goal. For these reasons, we evaluated the geographical location and gender distribution of the International Journal of Epidemiology peer reviewers for 2018.There were 695 peer reviewers hailing from 41 countries. 77% (533) of the reviewers were from 20% (8) of these countries, a classical 80:20 Pareto distrubution.41% (282) of peer reviewers were female. Although in line with the general underrepresentation of females reported in the literature, this proportion was much closer to parity than in other fields.Our investigation of peer reviewer ‘epidemiology’ demonstrates geographical and gender inequalities that can be further improved since diversity promotes innovation and a greater possibility for solving complex problems.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo specific funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset is publicly available.